Institute of Medical Biology (IMB), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
Skin Research Institute of Singapore (SRIS), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
EMBO J. 2021 Nov 2;40(21):e107839. doi: 10.15252/embj.2021107839. Epub 2021 Sep 15.
Adaptive evolution to cellular stress is a process implicated in a wide range of biological and clinical phenomena. Two major routes of adaptation have been identified: non-genetic changes, which allow expression of different phenotypes in novel environments, and genetic variation achieved by selection of fitter phenotypes. While these processes are broadly accepted, their temporal and epistatic features in the context of cellular evolution and emerging drug resistance are contentious. In this manuscript, we generated hypomorphic alleles of the essential nuclear pore complex (NPC) gene NUP58. By dissecting early and long-term mechanisms of adaptation in independent clones, we observed that early physiological adaptation correlated with transcriptome rewiring and upregulation of genes known to interact with the NPC; long-term adaptation and fitness recovery instead occurred via focal amplification of NUP58 and restoration of mutant protein expression. These data support the concept that early phenotypic plasticity allows later acquisition of genetic adaptations to a specific impairment. We propose this approach as a genetic model to mimic targeted drug therapy in human cells and to dissect mechanisms of adaptation.
细胞应激的适应性进化是一个涉及广泛生物和临床现象的过程。已经确定了两种主要的适应途径:非遗传变化,它允许在新环境中表达不同的表型,以及通过选择更适应的表型实现的遗传变异。虽然这些过程被广泛接受,但它们在细胞进化和新兴药物耐药性背景下的时间和上位性特征仍存在争议。在本手稿中,我们生成了必需核孔复合物(NPC)基因 NUP58 的功能获得性突变体。通过在独立克隆中剖析早期和长期的适应机制,我们观察到早期的生理适应与转录组重排以及与 NPC 相互作用的已知基因的上调相关;而长期的适应和适应性恢复则是通过 NUP58 的焦点扩增和突变蛋白表达的恢复来实现的。这些数据支持这样一种观点,即早期表型可塑性允许随后获得对特定损伤的遗传适应。我们建议将这种方法作为一种遗传模型,用于模拟人类细胞中的靶向药物治疗,并剖析适应机制。